FTC To Hold Open Meeting To Consider Key Policy Statement on Improper Patent Listings
Big Pharma Exploits FDA’s “Orange Book” to Prevent the Entry of Lower-Cost Generics and Block Competition
Text of Letter (PDF)
Washington, D.C. – U.S. Representative Pramila…
Progressive leaders in Senate and House demand answers from AI CEOs as they’re set to appear in Congress for special briefing
Lawmakers: “Tech companies must not build AI on the backs of exploited workers.”
Text of Letter (PDF)
Washington (September…
Washington, D.C. – US. Representative Pramila Jayapal (D-Wash.) and Senator Elizabeth Warren (D-Mass.) sent a letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration (FDA), urging him to close loopholes that pharmaceutical companies have exploited to block…
Text of Letter (PDF)
Washington (June 22, 2023) – Representative Pramila Jayapal (WA-07) and Senator Edward J. Markey (D-Mass.), a member of the Senate Commerce, Science, and Transportation Committee, led 15 of their colleagues in writing to Federal Trade Commission…
Washington, D.C. – U.S. Representative Pramila Jayapal (D-Wash.) and U.S. Senator Elizabeth Warren (D-Mass.) sent a letter to Kathi Vidal, Director of the United States Patent and Trademark Office (USPTO), calling on USPTO to take immediate action and use its…
WASHINGTON – U.S. Representatives Pramila Jayapal (WA-07) and Victoria Spartz (IN-05) are introducing bipartisan legislation to stop anticompetitive hospital conduct, which has been shown to lead to higher costs for patients and restricted care. The Stop Anticompetitive Healthcare Act would…
